Diversity and Proliferation of Metallo-β-Lactamases: a Clarion Call for Clinically Effective Metallo-β-Lactamase Inhibitors

Applied and Environmental Microbiology
Anou M SomboroLinda A Bester

Abstract

The worldwide proliferation of life-threatening metallo-β-lactamase (MBL)-producing Gram-negative bacteria is a serious concern to public health. MBLs are compromising the therapeutic efficacies of β-lactams, particularly carbapenems, which are last-resort antibiotics indicated for various multidrug-resistant bacterial infections. Inhibition of enzymes mediating antibiotic resistance in bacteria is one of the major promising means for overcoming bacterial resistance. Compounds having potential MBL-inhibitory activity have been reported, but none are currently under clinical trials. The need for developing safe and efficient MBL inhibitors (MBLIs) is obvious, particularly with the continuous spread of MBLs worldwide. In this review, the emergence and escalation of MBLs in Gram-negative bacteria are discussed. The relationships between different class B β-lactamases identified up to 2017 are represented by a phylogenetic tree and summarized. In addition, approved and/or clinical-phase serine β-lactamase inhibitors are recapitulated to reflect the successful advances made in developing class A β-lactamase inhibitors. Reported MBLIs, their inhibitory properties, and their purported modes of inhibition are delineated. Insights into ...Continue Reading

References

Jan 1, 1990·Journal of Medicinal Chemistry·R L RosatiJ A Retsema
Jan 1, 1966·The Biochemical Journal·L D Sabath, E P Abraham
Jun 1, 1967·The Biochemical Journal·S Kuwabara, E P Abraham
May 16, 1980·Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences·R P Ambler
Oct 1, 1982·Antimicrobial Agents and Chemotherapy·Y SainoS Mitsuhashi
Jun 21, 1994·Biochimica Et Biophysica Acta·T R WalshP M Bennett
Jan 1, 1996·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·W E Sanders, C C Sanders
Jan 1, 1997·Antimicrobial Agents and Chemotherapy·D J PayneJ Marchand-Brynaert
Mar 1, 1997·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·J T LiL Sun
Mar 1, 1996·The Journal of Antimicrobial Chemotherapy·T R WalshP M Bennett
Dec 24, 1997·Biological & Pharmaceutical Bulletin·M GotoY Arakawa
Apr 4, 1998·Antimicrobial Agents and Chemotherapy·T R WalshP M Bennett
Aug 4, 1998·The Journal of Antimicrobial Chemotherapy·D M Livermore
Apr 2, 1999·Natural Product Reports·A MatagneJ M Frère
Sep 25, 1999·Bioorganic & Medicinal Chemistry Letters·M L GreenleeJ H Epstein-Toney
Oct 6, 1999·Bioorganic & Medicinal Chemistry Letters·J H ToneyD E Vanderwall
Feb 22, 2001·Antimicrobial Agents and Chemotherapy·M GalleniUNKNOWN Metallo-beta-lactamases Working Group
Mar 16, 2001·Bioorganic & Medicinal Chemistry·S BounagaM I Page
Jun 8, 2001·The Journal of Biological Chemistry·J H ToneyY D Gao
Jul 4, 2001·European Journal of Biochemistry·A ZervosenM Galleni
Sep 21, 2001·The Journal of Biological Chemistry·C MollardG C Roberts
May 23, 2002·Antimicrobial Agents and Chemotherapy·David J PayneAlfonso Rivera-Sagredo
May 23, 2002·Antimicrobial Agents and Chemotherapy·Sandrine VessillierNicola Franceschini

❮ Previous
Next ❯

Citations

Jul 31, 2019·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·Raoudha DziriNaouel Klibi
Mar 30, 2019·The Journal of Infectious Diseases·Erlinda R UlloaVictor Nizet
Aug 31, 2019·Annals of the New York Academy of Sciences·Katlego KopotsaNontombi Marylucy Mbelle
Jun 7, 2020·Biomolecules·Antonella R PalaciosAlejandro J Vila
Sep 2, 2020·Journal of Biochemical and Molecular Toxicology·Simphiwe McoyiRene B Khan
Oct 3, 2020·The Journal of Antimicrobial Chemotherapy·Fanny BerglundErik Kristiansson
Oct 6, 2018·MedChemComm·Kamaleddin H M E Tehrani, Nathaniel I Martin
May 13, 2020·Archives of Toxicology·Christos T ChasapisMaria E Stefanidou
May 13, 2020·Expert Opinion on Therapeutic Patents·Nakita ReddyTricia Naicker
Sep 22, 2020·Critical Reviews in Microbiology·Syeda Fatima NadeemSalvatore Massa
Jul 13, 2020·Molecular Biology Reports·Payam BehzadiLernik Issakhanian
Nov 4, 2020·Future Microbiology·Matteo BassettiDaniele R Giacobbe
Nov 26, 2020·Chemistry : a European Journal·Matthijs J van HarenNathaniel I Martin
Dec 8, 2020·Journal of Inorganic Biochemistry·Luana La PianaGraziella Vecchio
Dec 10, 2020·International Journal of Molecular Sciences·Juan C Vázquez-UchaAlejandro Beceiro
Mar 11, 2021·Environmental Research·Marisa C NielsenSunny C Jiang
Mar 17, 2021·Proceedings of the National Academy of Sciences of the United States of America·Vikram Khipple MulliganDavid Baker
Oct 2, 2020·European Journal of Medicinal Chemistry·Lidia Moreira LimaEliezer J Barreiro
Apr 4, 2021·Animals : an Open Access Journal From MDPI·Thobeka P MthembuMohamed E El Zowalaty
May 19, 2021·ACS Infectious Diseases·Alistair J M FarleyChristopher J Schofield
Jul 27, 2021·Antimicrobial Agents and Chemotherapy·Liam A WilsonGerhard Schenk
Dec 14, 2021·The Journal of Organic Chemistry·Harjeet S SoorAndrei K Yudin

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Beta-lactamase Inhibitors

Beta-lactamase inhibitors are a class of antibiotics that inhibit beta-lactamases, a family of enzymes involved in bacterial resistance to beta-lactam antibiotics. Here is the latest research.

Beta-lactamase Inhibitors (ASM)

Beta-lactamase inhibitors are a class of antibiotics that inhibit beta-lactamases, a family of enzymes involved in bacterial resistance to beta-lactam antibiotics. Here is the latest research.

Carbapenems (ASM)

Carbapenems are members of the beta lactam class of antibiotics and are used for the treatment of severe or high-risk bacterial infections. Discover the latest research on carbapenems here.

Carbapenems

Carbapenems are members of the beta lactam class of antibiotics and are used for the treatment of severe or high-risk bacterial infections. Discover the latest research on carbapenems here.

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.